Lantern Pharma Inc. , a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial intelligence platform to transform oncology drug discovery and development, today announced ...

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration of ...

Clubroot disease, caused by Plasmodiophora brassicae, is a devastating soil-borne pathogen that severely threatens global ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

Microglia are the brain’s resident innate immune cells, that originate from early yolk sac progenitors and enter the developing central nervous system (CNS) ...

The field of bacteriophage research is rapidly evolving, offering new perspectives on the complex interplay between phages, bacteria, and host immune ...

Objectives To evaluate the long-term efficacy of remote ischaemic postconditioning (RIPC) on functional outcomes in patients with acute ischaemic stroke (AIS) who received intravenous thrombolysis ...